ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Apr 04, 2014 14:02 JST
Barclays Initiates Coverage of CMGE with an Overweight Rating and a 12-month Price Target of US$32
HONG KONG, Apr 04, 2014 - (ACN Newswire) - Barclays initiates coverage of China Mobile Games and Entertainment Group Limited ("CMGE" or the "Company") (Nasdaq: CMGE), the largest publisher and a leading developer of mobile games in China, with an Overweight rating and a 12-month price target of US$32.
Barclays issued a detailed report on CMGE on April 3, 2014. CMGE is given an Overweight rating and a 12-month price target of US$32, given its: 1) leading position in integrated mobile games publishing and development; 2) extensive and diversified games portfolio; and 3) multifaceted publishing channels/platforms. We expect potential share price catalysts from: 1) overseas expansion initiatives; 2) the traction and revenue opportunity from 51PK.com; and 3) the rising penetration of its Game Center app via MediaTek's handsets. Our US$32 price target is based on 15x our 2015E non-GAAP EPADS of US$2.13, implying a PEG ratio of 0.19x, which we believe is reasonable considering the hit-or-miss nature of new games' success, the shorter life cycle of mobile games, and potential execution risks.
Barclays believes that CMGE's integrated publishing and self-development model leads to a more diversified game portfolio and lower concentration of revenues compared to its peers. CMGE operates a total of 717 game titles, with 72 social games and 645 single player games as of end-2013. It plans to launch c50 new social games in 2014, 15 of which are to be self-developed. The contribution of social games to CMGE's revenue increased from 17.6% in 2012 to 63% in 2013.
Also, multifaceted publishing channels present good value proposition to developers. CMGE's broad and solid relationships with various distribution partners/platforms (including third-party app stores, telcos, chipset and handset manufacturers), as well as its in-house knowledge of games development, mean it presents a strong value proposition to small, fragmented mobile games developers.
Sectors: Daily Finance, IT Individual, Daily News
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event
Sep 03, 2025 12:30 JST
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Sep 03, 2025 11:32 JST
Anime Tokyo Station: TV Anime "SPY x FAMILY" Special Exhibition, Period: August 16 - November 9, 2025
Sep 03, 2025 11:00 JST
Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure
Sep 03, 2025 10:58 JST
Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT
Sep 02, 2025 12:50 JST
Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework "SAFe(R)"
Sep 02, 2025 11:50 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Sep 01, 2025 22:28 JST
DENSO Signs Agreement to Transfer Part of Its Ceramic Product Business
Sep 01, 2025 20:52 JST
Honda to Provide Official Vehicles for World Athletics Championships Tokyo 25 as Official Global Partner
Sep 01, 2025 13:50 JST
FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Sep 01, 2025 13:44 JST
TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) - Applications for Research Projects Open on September 1
Sep 01, 2025 11:00 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Aug 29, 2025 20:39 JST
Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building
Aug 29, 2025 18:54 JST
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma
Aug 29, 2025 18:17 JST
Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage
Aug 29, 2025 15:17 JST
Hong Kong Watch & Clock Fair, Salon de TIME return in September
Aug 28, 2025 21:27 JST
SenseTime Announces 2025 Interim Results
Aug 28, 2025 21:20 JST
Ausnutria 2025 Interim Results Announcement: Revenue and Profit Maintain Resilient Dual Growth
Aug 28, 2025 19:09 JST
Baguio Green Group (1397.HK) Announces 2025 Interim Results
Aug 28, 2025 19:03 JST
Production, Sales and Export Results for July, 2025
Aug 28, 2025 17:36 JST
More Latest Release >>